BRIEF-Lyell Immunopharma Q1 Net Income USD -52.195 Million

Reuters
14 May
BRIEF-Lyell Immunopharma Q1 Net Income USD -52.195 Million

May 13 (Reuters) - Lyell Immunopharma Q1 revenue USD 7 thousand.

  • Q1 operating expenses USD 57.374 million
  • Q1 adjusted net income USD -46.296 million
  • Q1 operating income USD -57.367 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10